CLL Monitoring, MRD Detection, Blood
Method Description Describes how the test is performed and provides a method-specific reference
Flow cytometric immunophenotyping (high sensitivity) of peripheral blood and bone marrow is performed to evaluate the presence or absence of chronic lymphocytic leukemia minimal residual disease using the following antibodies:
CLLM Panel: CD5, CD19, CD20, CD23, CD45, and kappa and lambda light chains.
(Flow Cytometry in Clinical Diagnosis. Fourth edition. Edited by P Keren, JP McCoy Jr, J Carey. ASCP Press, Chicago, IL, 2007)
Supplemental Report Indicates whether the report includes an additional document with charts, images or other enriched information
Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Specimens are processed and reported Monday through Saturday